MARIMED INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Marimed Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2016 to Q3 2024.
  • Marimed Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$1.68M, a 45.8% increase year-over-year.
  • Marimed Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$17.1M, a 84.1% decline year-over-year.
  • Marimed Inc. annual Nonoperating Income (Expense) for 2023 was -$21M, a 2337% decline from 2022.
  • Marimed Inc. annual Nonoperating Income (Expense) for 2022 was -$861K, a 71.7% increase from 2021.
  • Marimed Inc. annual Nonoperating Income (Expense) for 2021 was -$3.05M, a 69.6% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$17.1M -$1.68M +$1.42M +45.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$18.5M -$1.73M +$806K +31.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$19.3M -$1.62M +$1.68M +50.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$21M -$12M -$11.7M -3505% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$9.27M -$3.1M -$2.57M -485% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$6.71M -$2.54M -$1.69M -199% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$5.02M -$3.31M -$4.16M -488% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$861K -$334K +$101K +23.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$962K -$530K -$42K -8.61% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$920K -$849K -$249K -41.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$671K $852K +$2.38M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$3.05M -$435K +$1.32M +75.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-03
Q3 2021 -$4.37M -$488K +$1.21M +71.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$5.59M -$600K +$2.64M +81.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$8.23M -$1.52M +$1.81M +54.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$10M -$1.76M +$31.8M +94.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 -$41.8M -$1.7M +$5.67M +76.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$47.5M -$3.24M -$3.59M -1030% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$43.9M -$3.33M -$3.63M -1210% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$40.3M -$33.6M -$30.8M -1122% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 -$9.47M -$7.37M -$4.51M -157% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$4.96M $348K +$1.18M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$6.14M $300K +$1.81M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
Q4 2018 -$7.95M -$2.75M -$3.09M -907% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-01
Q3 2018 -$4.87M -$2.86M -$3.46M -576% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-29
Q2 2018 -$1.4M -$834K -$930K -966% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$473K -$1.51M -$1.63M -1367% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $1.16M $340K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 $601K +$539K +871% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $96.3K +$37.2K +62.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $119K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 $61.9K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $59.2K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.